[Anti-inflammatory effect of bimetopyrol. I. Suppressive effect on acute inflammation].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use* / Q000633:toxicity; D001241:Aspirin / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use; D004487:Edema / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D005334:Fever / Q000188:drug therapy; D005439:Flufenamic Acid / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006099:Granuloma / Q000188:drug therapy; D007213:Indomethacin / Q000627:therapeutic use; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D010653:Phenylbutazone / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use* / Q000633:toxicity; D051381:Rats; D011919:Rats, Inbred Strains; D014222:Triamcinolone Acetonide / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011758:Pyrroles; D003533:Cyproheptadine; D005439:Flufenamic Acid; D014222:Triamcinolone Acetonide; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin